Study to Assess Acute Vasodilation Response of Inhaled Nitric Oxide

NCT02436512 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Inability meet enrollment in study population.

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Inhaled Nitric Oxide

Sponsor

Geno LLC